Glutathione depletion in a liver microsomal assay as an in vitro biomarker for reactive metabolite formation

References

• AITIO, A. 1978, A simple and sensitive assay for 7-ethoxycoumarin deethylation. Analytical Biochemistry, 85, 488–491.
   PubMed Web of Science ®Google Scholar
• BUTLER, J. and HOEY, B. M. 1992, Reactions of glutathione and glutathione radicals with benzoquinones. Free Radicals in Biology and Medicine, 12, 337–345.
   PubMed Web of Science ®Google Scholar
• COHEN, S. D., PUMFORD, N. R., KHAIRALLAH, E. A., BOEKELHEIDE, K., POHL, L. R., AMOUZADEH, H. R. and HINSON, J. A. 1997, Selective protein covalent binding and target organ toxicity. Toxicology and Applied Pharmacology, 143, 1–12.
   PubMed Web of Science ®Google Scholar
• FENTEM, J. H. and FRY, J. R. 1991, Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities. Xenobiotica, 21, 895–904.
   PubMed Web of Science ®Google Scholar
• FORRESTER, L. M., HENDERSON, C. J., GLANCEY, M. J., BACK, D. J., PARK, B. K., BALL, S. E., KITTERINGHAM, N. R., MCLAREN, A. W., MILES, J. S., SKETT, P and WOLF, C. R. 1992, Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal, 281, 359–368.
   Google Scholar
• FRIEDMAN, P S., STRICKLAND, I., PIRMOHAMED, M. and PARK, B. K. 1994, Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Archives of Dermatology, 130, 598–604.
   PubMedGoogle Scholar
• FRY, J. R., FENTEM, J. H., SALIM, A., TANG, S. P A., GARLE, M. J. and WHITING, D. A. 1993, Structural requirements for the direct and cytochrome P450-dependent reaction of cyclic a,13-unsaturated carbonyl compounds with glutathione: a study with coumarin and related compounds. Journal of Pharmacy and Pharmacology, 45, 166–170.
   Google Scholar
• GARLE, M. J. and FRY, J. R. 1989, Detection of reactive metabolites in vitro. Toxicology, 54, 101–110.
   PubMed Web of Science ®Google Scholar
• GARLE, M. J., SINCLAIR, C., THURLEY, P and FRY, J. R. 1999, Haloalcohols deplete glutathione when incubated with fortified liver fractions. Xenobiotica, 29, 533–545.
   Google Scholar
• GEORGE, J., MURRAY, M., BYTH, K. and FARRELL, G. C. 1995, Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology, 21, 120–128.
   PubMed Web of Science ®Google Scholar
• GIBSON, G. G. and SKETT, P 1994, Introduction to Drug Metabolism (London: Chapman and Hall), pp. 228–230.
   Google Scholar
• GREGUS, Z. and KLAASSEN, C. D. 1996, Mechanisms of toxicity. In Casarett and Doull's Toxicology: the Basic Science of Toxicology, edited by C. D. Klaassen (New York: McGraw-Hill), pp. 35–74.
   Google Scholar
• HAMMOND, A. H., GARLE, M. J. and FRY, J. R. 1999, The nature of halogen substitution determines the mode of cytotoxicty of halopropanols . Toxicology and Applied Pharmacology, 155, 287-291.HISSIN, P J. and HILF, R. 1976, A fluorometric method for determination of oxidised and reduced glutathione in tissue. Analytical Biochemistry, 64, 214–226.
   Google Scholar
• KITTERINGHAM, N. R., LAMBERT, C., MAGGS, J. L., COLBERT, J. and PARK, B. K. 1988, A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. British Journal of Clinical Pharmacology, 26, 13–21.
   PubMed Web of Science ®Google Scholar
• LEEDER, J. S. 1998, Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia, 39 (Suppl. 7), S8—S16.
   Google Scholar
• LESSARD, E., FORTIN, A., BELANGER, PM., BEAUNE, P, HAMELIN, B. A. and TURGEON, J. 1996, Role of CYP2D6 in the N-hydroxylation of procainamide. Pharmacogenetics, 7, 381–390.
   Google Scholar
• LOWRY, D. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J. 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MAGGS, J. L., TINGLE, M. D., KITTERINGHAM, N. R. and PARK, B. K. 1988, Drug-protein conjugates—XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. Biochemical Pharmacology, 37, 303–311.
   PubMed Web of Science ®Google Scholar
• MARON, D. M. and AMES, B. N. 1983, Revised methods for the Salmonella mutagenicity test. Mutation Research, 113, 173–215.
   PubMed Web of Science ®Google Scholar
• MAYER, R. T., JERMYN, J. W, BURKE, M. D. and PROUGH, R. A. 1977, Methoxyresorufin as a substrate for the fluorimetric assay of insect microsomal 0-dealkylases. Pesticide Biochemistry and Physiology, 7, 349–356.
   Web of Science ®Google Scholar
• MINCHIN, R. E, Ho, P C. and BOYD, M. R. 1986, Reductive metabolism of nitrofurantoin by rat lung and liver in vitro. Biochemical Pharmacology, 35, 575–580.
   PubMed Web of Science ®Google Scholar
• MIURA, T., MURAOKA, S. and Dols°, T. 1992, Generation of semiquinone and oxygen radicals by the reaction of menadione with reduced glutathione at various pH. Chemical and Pharmaceutical Bulletin, 40, 709–712.
   Google Scholar
• MULDER, G. J. and LE, C. T. 1988, A rapid, simple in vitro screening test, using [11]glutathione and L-[35S]cysteine as trapping agents, to detect reactive intermediates of xenobiotics. Toxicology in Vitro, 2, 225–230.
   PubMed Web of Science ®Google Scholar
• O'BRIEN, P J. 1991, Molecular mechanisms of quinone cytotoxicity. Chemico-Biological Interactions, 80, 1–41.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R. 1964, The carbon monoxide binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. journal of Biological Chemistry, 239, 2370–2376.
   PubMed Web of Science ®Google Scholar
• PIRMOHAMED, M., KITTERINGHAM, N. R. and PARK, B. K. 1994, The role of active metabolites in drug toxicity. Drug Safety, 11, 114–144.
   PubMed Web of Science ®Google Scholar
• REED, D. J. 1985, Cellular defence mechanisms against reactive metabolites. In Bioactivation of Foreign Compounds, edited by M. W Anders (New York: Academic Press), pp. 71–108.
   Google Scholar
• ROSS, D. 1989, Mechanistic toxicology: a radical perspective. Journal of Pharmacy and Pharmacology, 41, 505–511.
   PubMed Web of Science ®Google Scholar
• SEDLACK, J. and LINDSAY, R. H. 1968, Estimation of total protein bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry, 25, 192–198.
   PubMed Web of Science ®Google Scholar
• SHARMA, M. and TOMASZ, M. 1994, Conjugation of glutathione and other thiols with bioreductively activated mitomycin c—effect of thiols on the reductive activation rate. Chemical Research in Toxicology, 7, 390–400.
   PubMed Web of Science ®Google Scholar
• SILVA, J. M., KHAN, S. and O'BRIEN, P J. 1993, Molecular mechanisms of nitrofurantoin-induced hepatocyte toxicity in aerobic versus hypoxic conditions. Archives of Biochemistry and Biophysics, 305, 362–369.
   Google Scholar
• THOR, H., MIRABELLI, E, SALIS, A., COHEN, G. M., BELLOMO, G. and ORRENIU SS. 1988, Alterations in hepatocyte cytoskeleton caused by redox cycling and alltylating quinones. Archives of Biochemistry and Biophysics, 266, 397–407.
   PubMed Web of Science ®Google Scholar
• UETRECHT, J. P 1988, Mechanism of drug-induced lupus. Chemical Research in Toxicology, 1, 133-143. WILKINSON, D. J. and FRY, J. R. 1995, Rat liver cytochrome P450-mediated metabolic activation of methoxsalen and structurally related compounds and its relation to enzyme inhibition. Journal ofPharmacy and Pharmacology, 47, 79–84.
   Google Scholar
• Yu, B. P 1994, Cellular defences against damage from reactive oxygen species. Pharmacological Reviews, 74, 139–162.
   Google Scholar